AIMS/HYPOTHESIS: The P12A variant in the PPARG gene and the E23K polymorphism in KCNJ11 are both known to influence individual predisposition to type 2 diabetes. If the effect of these variants on insulin secretion and action were to extend to an influence on early growth (which is largely mediated by insulin), it would offer an explanation for observed associations between low birthweight and subsequent diabetes. Since previous studies of the effects of these variants on early growth have been limited and conflicting, we examined these associations in a large, well-characterised birth cohort. METHODS: The P12A and E23K variants were genotyped in (respectively) 5,652 and 5,632 individuals from the Northern Finland Birth Cohort of 1966 and we sought associations with early growth phenotypes. RESULTS: Neither variant was associated with birthweight (P12A, p = 0.42; E23K, p = 0.44, additive models) or other measures of early growth. Although a previous report had suggested that the P12A effect on adult insulin sensitivity was restricted to small babies, we were unable to reproduce this finding (p = 0.40), nor did we confirm a previous report of an association with gestational age (p = 0.23). CONCLUSIONS/ INTERPRETATION: Despite a larger sample size than previous studies, we were unable to detect any effect of these variants on early growth. These findings do not support the notion that there are shared genetic determinants of low birthweight and adult diabetes.
AIMS/HYPOTHESIS: The P12A variant in the PPARG gene and the E23K polymorphism in KCNJ11 are both known to influence individual predisposition to type 2 diabetes. If the effect of these variants on insulin secretion and action were to extend to an influence on early growth (which is largely mediated by insulin), it would offer an explanation for observed associations between low birthweight and subsequent diabetes. Since previous studies of the effects of these variants on early growth have been limited and conflicting, we examined these associations in a large, well-characterised birth cohort. METHODS: The P12A and E23K variants were genotyped in (respectively) 5,652 and 5,632 individuals from the Northern Finland Birth Cohort of 1966 and we sought associations with early growth phenotypes. RESULTS: Neither variant was associated with birthweight (P12A, p = 0.42; E23K, p = 0.44, additive models) or other measures of early growth. Although a previous report had suggested that the P12A effect on adult insulin sensitivity was restricted to small babies, we were unable to reproduce this finding (p = 0.40), nor did we confirm a previous report of an association with gestational age (p = 0.23). CONCLUSIONS/ INTERPRETATION: Despite a larger sample size than previous studies, we were unable to detect any effect of these variants on early growth. These findings do not support the notion that there are shared genetic determinants of low birthweight and adult diabetes.
Authors: Aline Meirhaeghe; Colin A G Boreham; Liam J Murray; Florence Richard; George Davey Smith; Ian S Young; Philippe Amouyel Journal: Diabetes Date: 2007-02 Impact factor: 9.461
Authors: Johan G Eriksson; Virpi Lindi; Matti Uusitupa; Tom J Forsén; Markku Laakso; Clive Osmond; David J P Barker Journal: Diabetes Date: 2002-07 Impact factor: 9.461
Authors: Timothy M Frayling; Nicholas J Timpson; Michael N Weedon; Eleftheria Zeggini; Rachel M Freathy; Cecilia M Lindgren; John R B Perry; Katherine S Elliott; Hana Lango; Nigel W Rayner; Beverley Shields; Lorna W Harries; Jeffrey C Barrett; Sian Ellard; Christopher J Groves; Bridget Knight; Ann-Marie Patch; Andrew R Ness; Shah Ebrahim; Debbie A Lawlor; Susan M Ring; Yoav Ben-Shlomo; Marjo-Riitta Jarvelin; Ulla Sovio; Amanda J Bennett; David Melzer; Luigi Ferrucci; Ruth J F Loos; Inês Barroso; Nicholas J Wareham; Fredrik Karpe; Katharine R Owen; Lon R Cardon; Mark Walker; Graham A Hitman; Colin N A Palmer; Alex S F Doney; Andrew D Morris; George Davey Smith; Andrew T Hattersley; Mark I McCarthy Journal: Science Date: 2007-04-12 Impact factor: 47.728
Authors: Rachel M Freathy; Michael N Weedon; Amanda Bennett; Elina Hypponen; Caroline L Relton; Beatrice Knight; Beverley Shields; Kirstie S Parnell; Christopher J Groves; Susan M Ring; Marcus E Pembrey; Yoav Ben-Shlomo; David P Strachan; Chris Power; Marjo-Riitta Jarvelin; Mark I McCarthy; George Davey Smith; Andrew T Hattersley; Timothy M Frayling Journal: Am J Hum Genet Date: 2007-04-23 Impact factor: 11.025
Authors: Angharad R Morgan; John M D Thompson; Rinki Murphy; Peter N Black; Wen-Jiun Lam; Lynnette R Ferguson; Ed A Mitchell Journal: BMC Med Genet Date: 2010-08-16 Impact factor: 2.103
Authors: Ulla Sovio; Amanda J Bennett; Iona Y Millwood; John Molitor; Paul F O'Reilly; Nicholas J Timpson; Marika Kaakinen; Jaana Laitinen; Jari Haukka; Demetris Pillas; Ioanna Tzoulaki; Jassy Molitor; Clive Hoggart; Lachlan J M Coin; John Whittaker; Anneli Pouta; Anna-Liisa Hartikainen; Nelson B Freimer; Elisabeth Widen; Leena Peltonen; Paul Elliott; Mark I McCarthy; Marjo-Riitta Jarvelin Journal: PLoS Genet Date: 2009-03-06 Impact factor: 5.917
Authors: Rachel M Freathy; Amanda J Bennett; Susan M Ring; Beverley Shields; Christopher J Groves; Nicholas J Timpson; Michael N Weedon; Eleftheria Zeggini; Cecilia M Lindgren; Hana Lango; John R B Perry; Anneli Pouta; Aimo Ruokonen; Elina Hyppönen; Chris Power; Paul Elliott; David P Strachan; Marjo-Riitta Järvelin; George Davey Smith; Mark I McCarthy; Timothy M Frayling; Andrew T Hattersley Journal: Diabetes Date: 2009-02-19 Impact factor: 9.461
Authors: Dennis O Mook-Kanamori; Sandra W K de Kort; Cornelia M van Duijn; Andre G Uitterlinden; Albert Hofman; Henriëtte A Moll; Eric A P Steegers; Anita C S Hokken-Koelega; Vincent W V Jaddoe Journal: BMC Med Genet Date: 2009-07-17 Impact factor: 2.103
Authors: Dennis O Mook-Kanamori; Eric A P Steegers; Andre G Uitterlinden; Henriëtte A Moll; Cornelia M van Duijn; Albert Hofman; Vincent W V Jaddoe Journal: Diabetes Date: 2009-02-02 Impact factor: 9.461